These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 16968909

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT, Gbotosho GO, Folarin OA, Akinboye DO, Yusuf BO, Ebong OO, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM.
    Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
    [Abstract] [Full Text] [Related]

  • 3. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
    Biswas S.
    J Postgrad Med; 2004 Sep; 50(1):17-20. PubMed ID: 15047993
    [Abstract] [Full Text] [Related]

  • 4. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
    Mockenhaupt FP, Teun Bousema J, Eggelte TA, Schreiber J, Ehrhardt S, Wassilew N, Otchwemah RN, Sauerwein RW, Bienzle U.
    Trop Med Int Health; 2005 Sep; 10(9):901-8. PubMed ID: 16135198
    [Abstract] [Full Text] [Related]

  • 5. Dihydrofolate reductase I164L mutations in Plasmodium falciparum isolates: clinical outcome of 14 Kenyan adults infected with parasites harbouring the I164L mutation.
    Hamel MJ, Poe A, Bloland P, McCollum A, Zhou Z, Shi YP, Ouma P, Otieno K, Vulule J, Escalante A, Udhayakumar V, Slutsker L.
    Trans R Soc Trop Med Hyg; 2008 Apr; 102(4):338-45. PubMed ID: 18321547
    [Abstract] [Full Text] [Related]

  • 6. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
    Hapuarachchi HC, Dayanath MY, Bandara KB, Abeysundara S, Abeyewickreme W, de Silva NR, Hunt SY, Sibley CH.
    Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070
    [Abstract] [Full Text] [Related]

  • 7. Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria.
    Talisuna AO, Nalunkuma-Kazibwe A, Langi P, Mutabingwa TK, Watkins WW, Van Marck E, Egwang TG, D'Alessandro U.
    Infect Genet Evol; 2004 Dec; 4(4):321-7. PubMed ID: 15374529
    [Abstract] [Full Text] [Related]

  • 8. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
    Tahar R, Basco LK.
    Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
    [Abstract] [Full Text] [Related]

  • 9. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.
    Bwijo B, Kaneko A, Takechi M, Zungu IL, Moriyama Y, Lum JK, Tsukahara T, Mita T, Takahashi N, Bergqvist Y, Björkman A, Kobayakawa T.
    Acta Trop; 2003 Mar; 85(3):363-73. PubMed ID: 12659974
    [Abstract] [Full Text] [Related]

  • 10. Rapid selection of dhfr mutant allele in Plasmodium falciparum isolates after the introduction of sulfadoxine/pyrimethamine in combination with 4-aminoquinolines in Papua New Guinea.
    Mita T, Kaneko A, Hwaihwanje I, Tsukahara T, Takahashi N, Osawa H, Tanabe K, Kobayakawa T, Björkman A.
    Infect Genet Evol; 2006 Nov; 6(6):447-52. PubMed ID: 16600696
    [Abstract] [Full Text] [Related]

  • 11. Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
    Barnes KI, Little F, Mabuza A, Mngomezulu N, Govere J, Durrheim D, Roper C, Watkins B, White NJ.
    J Infect Dis; 2008 Jun 01; 197(11):1605-13. PubMed ID: 18471066
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
    Mugittu K, Ndejembi M, Malisa A, Lemnge M, Premji Z, Mwita A, Nkya W, Kataraihya J, Abdulla S, Beck HP, Mshinda H.
    Am J Trop Med Hyg; 2004 Dec 01; 71(6):696-702. PubMed ID: 15642957
    [Abstract] [Full Text] [Related]

  • 13. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
    Al-Saai S, Kheir A, Abdel-Muhsin AM, Al-Ghazali A, Nwakanma D, Swedberg G, Babiker HA.
    Infect Genet Evol; 2009 Sep 01; 9(5):778-83. PubMed ID: 19379843
    [Abstract] [Full Text] [Related]

  • 14. Principal role of dihydropteroate synthase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda.
    Dorsey G, Dokomajilar C, Kiggundu M, Staedke SG, Kamya MR, Rosenthal PJ.
    Am J Trop Med Hyg; 2004 Dec 01; 71(6):758-63. PubMed ID: 15642967
    [Abstract] [Full Text] [Related]

  • 15. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes.
    Méndez F, Herrera S, Murrain B, Gutiérrez A, Moreno LA, Manzano M, Muñoz A, Plowe CV.
    Am J Trop Med Hyg; 2007 Sep 01; 77(3):438-43. PubMed ID: 17827356
    [Abstract] [Full Text] [Related]

  • 16. Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria.
    Kyabayinze D, Cattamanchi A, Kamya MR, Rosenthal PJ, Dorsey G.
    Am J Trop Med Hyg; 2003 Sep 01; 69(3):247-52. PubMed ID: 14628939
    [Abstract] [Full Text] [Related]

  • 17. Sulfadoxine-pyrimethamine parasitological efficacy against Plasmodium falciparum among pregnant women and molecular markers of resistance in Zambia: an observational cohort study.
    Chaponda EB, Mharakurwa S, Michelo C, Bruce J, Chandramoha D, Matthew Chico R.
    Malar J; 2021 Jan 22; 20(1):61. PubMed ID: 33482823
    [Abstract] [Full Text] [Related]

  • 18. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
    A-Elbasit IE, Alifrangis M, Khalil IF, Bygbjerg IC, Masuadi EM, Elbashir MI, Giha HA.
    Malar J; 2007 Aug 08; 6():108. PubMed ID: 17686173
    [Abstract] [Full Text] [Related]

  • 19. Molecular surveillance of mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum in Ethiopia.
    Gebru-Woldearegai T, Hailu A, Grobusch MP, Kun JF.
    Am J Trop Med Hyg; 2005 Dec 08; 73(6):1131-4. PubMed ID: 16354825
    [Abstract] [Full Text] [Related]

  • 20. Plasmodium falciparum: evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of sulfadoxine-pyrimethamine treatment of uncomplicated malaria.
    Omar SA, Mens PF, Schoone GJ, Yusuf A, Mwangi J, Kaniaru S, Omer GA, Schallig HD.
    Exp Parasitol; 2005 May 08; 110(1):73-9. PubMed ID: 15804381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.